Author:
Gogna Navdeep,Hyde Lillian F.,Collin Gayle B.,Stone Lisa,Naggert Jurgen K.,Nishina Patsy M.
Publisher
Springer International Publishing
Reference130 articles.
1. VISION 2020 Global Initiative for the Elimination of Avoidable Blindness: Action plan 2006–2011. VISION 2020 Global Initiative for the Elimination of Avoidable Blindness: Action plan 2006–2011; 2007.
2. de Jong EK, Geerlings MJ, den Hollander AI. Chapter 10 – Age-related macular degeneration. In: Genetics and genomics of eye disease. London: Academic; 2020. p. 155–80.
3. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol. 2009;127(4):533–40.
4. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16.
5. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358(24):2606–17.